Private Advisor Group, LLC Eli Lilly & CO Transaction History

Private Advisor Group, LLC

$14.8 Billion
Q2 2024

A detailed history of Private Advisor Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Private Advisor Group, LLC holds 80,401 shares of LLY stock, worth $72.6 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

80,401

Previous 76,282 5.4%

Holding current value

$72.6 Million

Previous $59.3 Million 22.66%

% of portfolio

0.49%

Previous 0.43%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$724.87 - $909.04 $2.99 Million - $3.74 Million	4,119 Added 5.4%	80,401 $72.8 Million
Q1 2024 Apr 30, 2024	BUY	$592.2 - $792.28 $76,986 - $102,996	130 Added 0.17%	76,282 $59.3 Million
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $1.69 Million - $1.99 Million	3,222 Added 4.42%	76,152 $44.4 Million
Q3 2023 Nov 02, 2023	BUY	$434.7 - $599.3 $188,659 - $260,096	434 Added 0.6%	72,930 $39.2 Million
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $443,686 - $593,259	1,265 Added 1.78%	72,496 $34 Million
Q1 2023 May 10, 2023	BUY	$310.63 - $364.82 $685,560 - $805,157	2,207 Added 3.2%	71,231 $24.5 Million
Q4 2022 Jan 18, 2023	BUY	$321.55 - $374.67 $1.84 Million - $2.15 Million	5,737 Added 9.07%	69,024 $0
Q3 2022 Oct 14, 2022	SELL	$296.48 - $337.87 $13.3 Million - $15.2 Million	-44,936 Reduced 41.52%	63,287 $20.5 Million
Q2 2022 Jul 13, 2022	BUY	$278.73 - $327.27 $2.98 Million - $3.5 Million	10,694 Added 10.96%	108,223 $35.1 Million
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $372,218 - $462,572	-1,586 Reduced 1.6%	97,529 $27.9 Million
Q4 2021 Feb 10, 2022	SELL	$224.85 - $279.04 $10.3 Million - $12.8 Million	-46,021 Reduced 31.71%	99,115 $27.4 Million
Q3 2021 Oct 14, 2021	BUY	$221.6 - $272.71 $13.1 Million - $16.1 Million	59,135 Added 68.76%	145,136 $33.5 Million
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $1.45 Million - $1.88 Million	-8,035 Reduced 8.54%	86,001 $19.7 Million
Q1 2021 Apr 22, 2021	BUY	$164.32 - $212.72 $5.72 Million - $7.4 Million	34,792 Added 58.73%	94,036 $17.6 Million
Q4 2020 Apr 01, 2021	SELL	$130.46 - $172.63 $122,632 - $162,272	-940 Reduced 1.56%	59,244 $10 Million
Q3 2020 Nov 02, 2020	BUY	$146.22 - $169.13 $84,807 - $98,095	580 Added 0.97%	60,184 $9.11 Million
Q2 2020 Aug 17, 2020	BUY	$136.42 - $164.18 $125,779 - $151,373	922 Added 1.57%	59,604 $9.79 Million
Q1 2020 May 12, 2020	BUY	$119.05 - $147.35 $83,454 - $103,292	701 Added 1.21%	58,682 $8.14 Million
Q4 2019 Feb 10, 2020	SELL	$106.92 - $132.43 $259,387 - $321,275	-2,426 Reduced 4.02%	57,981 $7.62 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $5.15 Million - $5.61 Million	-48,271 Reduced 44.42%	60,407 $6.76 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $6.4 Million - $7.47 Million	57,755 Added 113.42%	108,678 $12 Million
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $87,378 - $102,850	-785 Reduced 1.52%	50,923 $6.6 Million
Q4 2018 Feb 11, 2019	SELL	$105.9 - $118.64 $966,019 - $1.08 Million	-9,122 Reduced 15.0%	51,708 $5.98 Million
Q3 2018 Nov 01, 2018	BUY	$85.86 - $107.31 $1.81 Million - $2.26 Million	21,056 Added 52.94%	60,830 $6.53 Million
Q2 2018 Aug 09, 2018	BUY	$75.7 - $86.88 $536,258 - $615,457	7,084 Added 21.67%	39,774 $3.41 Million
Q1 2018 May 09, 2018	SELL	$74.21 - $87.6 $1.31 Million - $1.55 Million	-17,709 Reduced 35.14%	32,690 $2.53 Million
Q4 2017 Feb 07, 2018	SELL	$81.94 - $87.89 $1.89 Million - $2.03 Million	-23,122 Reduced 31.45%	50,399 $4.33 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $278,608 - $309,227	3,615 Added 5.17%	73,521 $6.39 Million
Q2 2017 Aug 10, 2017	BUY	N/A	69,906	69,906 $5.75 Million

Others Institutions Holding LLY

# of Institutions

3,865

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $858B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Account

Private Advisor Group, LLC Eli Lilly & CO Transaction History